MedRiseStep 2 CK QBank

QBank › Practice questions › Persistent asthma: stepping up controller therapy

Free Step 2 CK practice question

Persistent asthma: stepping up controller therapy

An original MedRise vignette in the Step 2 CK style. Choose your answer first, then open the explanation.

A 9-year-old girl is brought to the pediatrician by her mother for follow-up of asthma diagnosed 1 year ago. Over the past 2 months she has used her albuterol inhaler 3 to 4 days per week and has awakened with cough about 3 nights per month. Coughing sometimes makes her stop during soccer games. She went to the emergency department once 6 months ago and has never been hospitalized. She takes no other medications. Her mother smokes outside the home. Her temperature is 37.0°C (98.6°F), pulse is 88/min, respirations are 18/min, and oxygen saturation is 98% on room air. Lungs are clear with a faint end-expiratory wheeze on forced exhalation. Spirometry shows FEV1 84% of predicted, FEV1/FVC 0.80, and a 14% increase in FEV1 after bronchodilator. Inhaler technique is correct. Which of the following is the most appropriate change to her regimen?

  1. Add daily oral montelukast as the sole controller
  2. Add daily low-dose inhaled fluticasone
  3. Add daily oral prednisone
  4. Add daily inhaled salmeterol as the sole controller
  5. Schedule albuterol four times daily
Show the answer and explanation

Correct answer: B. Add daily low-dose inhaled fluticasone

Symptoms more than 2 days per week but not daily, and nighttime awakenings 3-4 times per month, with FEV1 >80% of predicted, classify her asthma as mild persistent. The preferred controller for mild persistent asthma in children is a daily low-dose inhaled corticosteroid, which reduces exacerbations and improves lung function more effectively than any alternative. Leukotriene receptor antagonists are an alternative but less effective option, and long-acting beta agonists must never be used without an inhaled corticosteroid.

Why each option is right or wrong

  1. Add daily oral montelukast as the sole controllerMontelukast is an alternative, less effective step 2 option and also carries a boxed warning for neuropsychiatric effects.
  2. Add daily low-dose inhaled fluticasoneCorrect: daily low-dose inhaled corticosteroid is the preferred step 2 controller for mild persistent asthma.
  3. Add daily oral prednisoneChronic systemic steroids are reserved for severe persistent asthma refractory to other therapy because of major adverse effects.
  4. Add daily inhaled salmeterol as the sole controllerLong-acting beta agonist monotherapy increases asthma-related death and is contraindicated without an inhaled corticosteroid.
  5. Schedule albuterol four times dailyScheduled short-acting beta agonist provides no anti-inflammatory control and masks worsening disease.

Mild persistent asthma (symptoms >2 days/week, night symptoms 3-4/month, FEV1 >80%): add daily low-dose inhaled corticosteroid; never use LABA monotherapy.

References

  1. Asthma Medication in Children (StatPearls, NCBI Bookshelf)

Missed it? Find out why.

Open this question in the QBank to work it with the Socratic tutor, or take the free Plateau Diagnostic to see which kind of mistake is behind your misses.

Practice in the QBank

More free practice questions

Why MedRise instead of another question bank

What you needTypical question bankMedRise QBank
Know why you missA percent correct by subjectAn Error Profile that shows which kind of mistake is behind your misses
Help on a hard questionA long explanation to readA Socratic AI tutor that asks until you can explain it yourself
DifficultyThe same set for everyoneAdaptive mode that gets harder as you improve
Trying itSign up or pay first20 free questions and a free Plateau Diagnostic, no account